- Home
- XPON vs CPHI Comparison
XPON vs CPHI Comparison
Compare XPON & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPON
- CPHI
- Stock Information
- Founded
- XPON 2016
- CPHI N/A
- Country
- XPON United States
- CPHI China
- Employees
- XPON N/A
- CPHI N/A
- Industry
- XPON Electronic Components
- CPHI Biotechnology: Pharmaceutical Preparations
- Sector
- XPON Technology
- CPHI Health Care
- Exchange
- XPON Nasdaq
- CPHI Nasdaq
- Market Cap
- XPON 6.2M
- CPHI 5.3M
- IPO Year
- XPON 2022
- CPHI N/A
- Fundamental
- Price
- XPON $1.21
- CPHI $1.51
- Analyst Decision
- XPON
- CPHI
- Analyst Count
- XPON 0
- CPHI 0
- Target Price
- XPON N/A
- CPHI N/A
- AVG Volume (30 Days)
- XPON 2.0M
- CPHI 8.2K
- Earning Date
- XPON 11-13-2025
- CPHI 11-13-2025
- Dividend Yield
- XPON N/A
- CPHI N/A
- EPS Growth
- XPON N/A
- CPHI N/A
- EPS
- XPON N/A
- CPHI N/A
- Revenue
- XPON $9,417,947.00
- CPHI $4,052,266.00
- Revenue This Year
- XPON $61.26
- CPHI N/A
- Revenue Next Year
- XPON N/A
- CPHI N/A
- P/E Ratio
- XPON N/A
- CPHI N/A
- Revenue Growth
- XPON 109.37
- CPHI N/A
- 52 Week Low
- XPON $0.60
- CPHI $1.20
- 52 Week High
- XPON $5.50
- CPHI $3.35
- Technical
- Relative Strength Index (RSI)
- XPON 40.65
- CPHI 32.84
- Support Level
- XPON $1.11
- CPHI $1.46
- Resistance Level
- XPON $1.32
- CPHI $1.58
- Average True Range (ATR)
- XPON 0.11
- CPHI 0.07
- MACD
- XPON -0.00
- CPHI -0.01
- Stochastic Oscillator
- XPON 18.32
- CPHI 11.57
About XPON Expion360 Inc.
Expion360 Inc is focused on the design, assembly, manufacturing, and sales of lithium iron phosphate (LiFePO4) batteries and supporting accessories for recreational vehicles (RV's) and marine applications with plans to expand into home energy storage products and industrial applications. Its product offerings include some of the minimal-footprint batteries in the RV & Marine industry.
About CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.